SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-18-013238
Filing Date
2018-09-28
Accepted
2018-09-28 17:19:22
Documents
68
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2018_relmadatherapeutics.htm 10-K 1211498
2 CERTIFICATION f10k2018ex31-1_relmada.htm EX-31.1 7699
3 CERTIFICATION f10k2018ex31-2_relmada.htm EX-31.2 7877
4 CERTIFICATION f10k2018ex32-1_relmada.htm EX-32.1 3505
5 CERTIFICATION f10k2018ex32-2_relmada.htm EX-32.2 3468
  Complete submission text file 0001213900-18-013238.txt   4215319

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rlmd-20180630.xml EX-101.INS 564479
7 XBRL SCHEMA FILE rlmd-20180630.xsd EX-101.SCH 44474
8 XBRL CALCULATION FILE rlmd-20180630_cal.xml EX-101.CAL 52580
9 XBRL DEFINITION FILE rlmd-20180630_def.xml EX-101.DEF 200784
10 XBRL LABEL FILE rlmd-20180630_lab.xml EX-101.LAB 354655
11 XBRL PRESENTATION FILE rlmd-20180630_pre.xml EX-101.PRE 281093
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 646-677-3853
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55347 | Film No.: 181094989
SIC: 2834 Pharmaceutical Preparations